Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stenke

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1993
Regulation of granulocytosis in inflammatory disease and in leukemiaP Reizenstein, L Stenke
Lakartidningen|March 25, 1992
[Erythropoietin is not only for patients with renal diseases--new indications in sight]R Hast, L Stenke
Transfusion|September 1, 1990
The effect of different agitation modes on platelet metabolism, thromboxane formation, and alpha-granular release during platelet storageJ Wallvik, L Stenke, O Akerblom
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Treatment of poor prognosis acute myeloid leukemia with aggressive and non-aggressive chemotherapyL Stenke, R Hast, P Reizenstein
Lakartidningen|February 25, 2000
[Radioimmunotherapy is rapidly developing to clinically efficient therapy]L Stenke, R Lewensohn, J Carlsson
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Increased leukotriene C4 production in chronic myelogenous leukemiaL Stenke, P Reizenstein, J A Lindgren
Leukemia Research|October 1, 1994
Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesisL Stenke, P Reizenstein, J A Lindgren
European Journal of Biochemistry|July 15, 1991
On the mechanism of transcellular lipoxin formation in human platelets and granulocytesC Edenius, L Stenke, J A Lindgren
Journal of Internal Medicine|April 1, 1991
Response to recombinant human erythropoietin treatment in myelodysplastic syndromes (MDS)R Hast, F Celsing, M Ekman, et al.
Oncology|January 1, 1990
Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemiaM Björkholm, J Björnsdottir, L Stenke, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Medical Oncology and Tumor Pharmacotherapy|January 1, 1993
Regulation of granulocytosis in inflammatory disease and in leukemiaP Reizenstein, L Stenke
Lakartidningen|March 25, 1992
[Erythropoietin is not only for patients with renal diseases--new indications in sight]R Hast, L Stenke
Transfusion|September 1, 1990
The effect of different agitation modes on platelet metabolism, thromboxane formation, and alpha-granular release during platelet storageJ Wallvik, L Stenke, O Akerblom
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Treatment of poor prognosis acute myeloid leukemia with aggressive and non-aggressive chemotherapyL Stenke, R Hast, P Reizenstein
Lakartidningen|February 25, 2000
[Radioimmunotherapy is rapidly developing to clinically efficient therapy]L Stenke, R Lewensohn, J Carlsson
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Increased leukotriene C4 production in chronic myelogenous leukemiaL Stenke, P Reizenstein, J A Lindgren
Leukemia Research|October 1, 1994
Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesisL Stenke, P Reizenstein, J A Lindgren
European Journal of Biochemistry|July 15, 1991
On the mechanism of transcellular lipoxin formation in human platelets and granulocytesC Edenius, L Stenke, J A Lindgren
Journal of Internal Medicine|April 1, 1991
Response to recombinant human erythropoietin treatment in myelodysplastic syndromes (MDS)R Hast, F Celsing, M Ekman, et al.
Oncology|January 1, 1990
Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemiaM Björkholm, J Björnsdottir, L Stenke, et al.
Pageof 6